CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration
暂无分享,去创建一个
Yinglu Guo | Xinyu Yang | Zicheng Wang | W. Qiu | Yinglu Guo | Xuesong Li | Yanqing Gong | Wei Qiu | Xianghui Ning | Libo Liu | Jian Lin | Xuesong Li | X. Ning | Y. Gong | Li-bo Liu | Jian Lin | Zicheng Wang | Xinyu Yang
[1] C. Cordon-Cardo,et al. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. , 2007, The Journal of clinical investigation.
[2] Junjie Chen,et al. CCDC98 is a BRCA1-BRCT domain–binding protein involved in the DNA damage response , 2007, Nature Structural &Molecular Biology.
[3] S. Koul,et al. Role of p38 MAP Kinase Signal Transduction in Solid Tumors. , 2013, Genes & cancer.
[4] Ming Chen,et al. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells. , 2009, Carcinogenesis.
[5] Masayuki Takahashi,et al. Role of phosphatidylinositol‐3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor‐related apoptosis‐inducing ligand , 2006, Cancer science.
[6] H. Nothwang,et al. Cloning and characterization of the breakpoint regions of a chromosome 11;18 translocation in a patient with hamartoma of the retinal pigment epithelium , 2001, Cytogenetic and Genome Research.
[7] L. Kiemeney,et al. Epidemiology and risk factors of urothelial bladder cancer. , 2013, European urology.
[8] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[9] D. Zhang,et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells , 2009, Oncogene.
[10] J. Stetefeld,et al. The use of coiled-coil proteins in drug delivery systems , 2009, European Journal of Pharmacology.
[11] Junxia Chen,et al. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. , 2014, Cellular signalling.
[12] M. Caraglia,et al. Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells , 2013, Cell Death and Disease.
[13] Li Lin,et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. , 2011, Cancer cell.
[14] CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway , 2012, Molecular and Cellular Biochemistry.
[15] Oh-Hyung Kwon,et al. Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer. , 2012, Carcinogenesis.
[16] B. Jiang,et al. PI3K/PTEN signaling in angiogenesis and tumorigenesis. , 2009, Advances in cancer research.
[17] Scott M Lippman,et al. Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.
[18] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[19] T. Pawson,et al. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner , 2014, Oncogene.
[20] S. Novaković,et al. KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study , 2012, BMC Cancer.
[21] Y. Lei,et al. Mitogen-activated protein kinase signal transduction in solid tumors. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[22] Eytan Domany,et al. Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer , 2009, Proceedings of the National Academy of Sciences.
[23] A. Cheung,et al. PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma , 2015, Oncotarget.
[24] J. Hou,et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. , 2013, The Journal of urology.
[25] Zhen Liu,et al. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanism , 2011, International journal of cancer.
[26] M. Islam,et al. Expression of the coiled coil domain containing protein 116 in the pancreatic islets and endocrine pancreatic tumors , 2012, Islets.